Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nathalie Garstka"'
Autor:
Iris E. Ertl, Robert Brettner, Hannah Kronabitter, Thomas Mohr, Sophia Derdak, Markus Jeitler, Martin Bilban, Nathalie Garstka, Shahrokh F. Shariat
Publikováno v:
Cells, Vol 12, Iss 1, p 124 (2022)
Previous studies have demonstrated an involvement of chromatin-remodelling SWI/SNF complexes in the development of prostate cancer, suggesting both tumor suppressor and oncogenic activities. SMARCD1/BAF60A, SMARCD2/BAF60B, and SMARCD3/BAF60C are mutu
Externí odkaz:
https://doaj.org/article/218cab34a57f4e719a0b0b6632e36fc7
Autor:
Daniela Bovenkamp, Ryan Sentosa, Elisabet Rank, Mikael T. Erkkilä, Fabian Placzek, Jeremias Püls, Wolfgang Drexler, Rainer A. Leitgeb, Nathalie Garstka, Shahrokh F. Shariat, Clara Stiebing, Iwan W. Schie, Jürgen Popp, Marco Andreana, Angelika Unterhuber
Publikováno v:
Applied Sciences, Vol 8, Iss 12, p 2371 (2018)
We present a combination of optical coherence tomography (OCT) and Raman spectroscopy (RS) for improved diagnosis and discrimination of different stages and grades of bladder cancer ex vivo by linking the complementary information provided by these t
Externí odkaz:
https://doaj.org/article/d51231b349c146a2ab75e09f32731d5e
Publikováno v:
Current opinion in urology. 33(1)
Adrenocortical carcinoma (ACC) is a rare, aggressive disease with a paucity of data and great variability between published studies regarding its treatment. This review provides information on current clinical management and oncological and endocrine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89af8e60cf746a88efe3aaa13f61ed71
https://pubmed.ncbi.nlm.nih.gov/36444650
https://pubmed.ncbi.nlm.nih.gov/36444650
Autor:
Nathalie Garstka, Mesut Remzi
Publikováno v:
Current opinion in urology. 33(1)
Adrenal lesions are commonly discovered on abdominal imaging studies, whereas some patients with adrenal tumors present with symptoms of homonal excess. They are categorized as either hormone active or inactive and either as benign or malignant. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab62f9b90e98197103637dee358f56b9
https://pubmed.ncbi.nlm.nih.gov/36239402
https://pubmed.ncbi.nlm.nih.gov/36239402
Autor:
Nathalie Garstka, Shahrokh F. Shariat
Publikováno v:
Journal für Urologie und Urogynäkologie/Österreich. 28:29-33
ZusammenfassungFrauen werden bis zur endgültigen Diagnosestellung eines Harnblasenkarzinoms (BCa) häufiger symptomatisch fehlbehandelt, wodurch es zu einer Diagnoseverzögerung kommt. Bei Frauen wird zum Zeitpunkt der Erstdiagnose eher ein fortgesc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dde2768105bb209a3e3b91ab45033768
https://doi.org/10.1007/s41972-021-00138-6
https://doi.org/10.1007/s41972-021-00138-6
Autor:
Wolfgang Wadsak, Nikolaus Krall, Lukas Nics, Alexander Haug, Oana C. Kulterer, Samuele Cazzamalli, Markus Mitterhauser, Mesut Remzi, Sarah Pfaff, Chrysoula Vraka, Franziska Bootz, Dario Neri, Nathalie Garstka
Publikováno v:
The Journal of Nuclear Medicine, 62 (3)
99mTc-PHC-102 is a 99mTc-labeled derivative of acetazolamide, a high-affinity small organic ligand of Carbonic Anhydrase IX (CAIX). 99mTc-PHC-102 has previously shown favourable in vivo biodistribution properties in mouse models of CAIX-positive clea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab1074179f0fcdb122fbdfa90f08d23
https://doi.org/10.2967/jnumed.120.245530
https://doi.org/10.2967/jnumed.120.245530
Autor:
Martin Susani, Petr Glybochko, Dmitry Enikeev, Andrea Haitel, Shahrokh F. Shariat, Ursula Lemberger, Nathalie Garstka, Melanie R. Hassler, Gero Kramer, Bernhard Grubmüller, Judith Stangl-Kremser
Publikováno v:
Biomarkers. 25:268-273
Purpose: To assess the prognostic significance of the nuclear receptor binding SET protein 2 (NSD2), a co-activator of the NFkB-pathway, on tumour progression in patients with advanced prostate can...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d754ec538be5a2746663daf599fa2ec
https://doi.org/10.1080/1354750x.2020.1734861
https://doi.org/10.1080/1354750x.2020.1734861
Autor:
Nathalie Garstka, Shahrokh F. Shariat
Publikováno v:
Journal für Urologie und Urogynäkologie/Österreich. 27:66-69
ZusammenfassungDas Outcome eines lymphknotenpositiven oder fernmetastasierten Urothelkarzinoms (mUC) der Harnblase ist schlecht. Eine cisplatinbasierte Chemotherapie wie Gemcitabin/Cisplatin oder akzeleriertes MVAC (Methotrexat, Vinblastin, Adriamyci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1d6eede3265a3cd3d2a373afbb54663
https://doi.org/10.1007/s41972-020-00094-7
https://doi.org/10.1007/s41972-020-00094-7
Publikováno v:
Uro-News. 23:38-43
Das Urothelkarzinom des oberen Harntrakts ist eine seltene urologische Krebserkrankung. Aufgrund der geringen Inzidenz gibt es bislang nur wenige randomisierte klinische Studien, insbesondere im fortgeschrittenen Stadium ist die chirurgische Therapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c412f07fbdc395fd9bf6b6791f5b07a
https://doi.org/10.1007/s00092-019-2060-1
https://doi.org/10.1007/s00092-019-2060-1
Autor:
Shahrokh F. Shariat, Pascal A. T. Baltzer, Nathalie Garstka, Thomas H. Helbich, Jasmin Gmeiner
Publikováno v:
European journal of radiology. 142
Purpose To investigate the diagnostic performance of the overall Vesical Imaging Reporting and Data System (VI-RADS) score and its individual magnetic resonance imaging (MRI) parameters in assessing grade and muscle invasiveness of bladder cancer (BC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bb5136ae8dce2a2ae05a0af5adfa649
https://pubmed.ncbi.nlm.nih.gov/34252867
https://pubmed.ncbi.nlm.nih.gov/34252867